期刊文献+

针对阿司匹林抵抗的血小板功能检测合理吗? 被引量:2

Is platelet function testing for aspirin resistance reasonable to do?
原文传递
导出
摘要 阿司匹林抵抗是缺血性卒中预防实践中的常见问题.当前,对阿司匹林抵抗如何进行管理尚未达成共识.此外,是否应针对阿司匹林抵抗常规进行血小板功能检测,进而指导抗血小板治疗是否合理也存在广泛争议. Aspirin resistance is a common question for the preventive practice of ischemic stroke.Currently,it has not yet reached a consensus on how to manage aspirin resistance.In addition,whether to perform the detection of routine platelet function for aspirin resistance,and then whether to guide antiplatelet therapy is reasonable also have widespread cortroversy.
机构地区 解放军
出处 《国际脑血管病杂志》 北大核心 2010年第9期716-720,共5页 International Journal of Cerebrovascular Diseases
  • 相关文献

同被引文献90

  • 1Furie KL,Kasner SE,Adams RJ,et al; American Heart Association Stroke Council,Council on Cardiovascular Nursing,Council on Clinical Cardiology,and Interdisciplinary Council on Quality of Care and Outcomes Research.Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack:a guideline for healthcare professionals from the american heart association/american stroke association.Stroke,2011,42:227-276.
  • 2Angiolillo D J,Fernandez-Ortiz A,Bernardo E,et al.Variability in individual responsiveness to clopidogrel:clinical implications,management,and future perspectives.J Am Coll Cardiol,2007,49:1505-1516.
  • 3Bhatt DL.Aspirin resistance:more than just a laboratory curiosity.J Am Coil Cardiol,2004,43:1127-1129.
  • 4Alberts MJ.Platelet function testing for aspirin resistance is reasonable to do:yes! Stroke,2010,41:2400-2401.
  • 5Bliden KP,DiChiara J,Tantry US,et al.Increased risk in patients with high platelet aggregation receiving chronic clopidogrel therapy undergoing percutaneous coronary intervention:is the current antiplatelet therapy adequate? J Am Coll Cardiol,2007,49:657-666.
  • 6van Werkum JW,van der Stelt CA,Seesing TH,et al.A head-tohead comparison between the VerifyNow P2Y12 assay and light transmittance aggregometry for monitoring the individual platelet response to clopidogrel in patients undergoing elective percutaneous coronary intervention.J Thromb Haemost,2006,4:2516-2518.
  • 7Rowe AS,Greene CL,Snider CC,et al.Thromboelastographic changes in patients experiencing an acute ischemic stroke and receiving alteplase.J Stroke Cerebrovasc Dis,2014,23:1307-1311.
  • 8Kreutz RP,Owens J,Breall JA,et al.C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting.Blood Coagul Fibrinolysis,2013,24:321-326.
  • 9Rafil S,Johansson PI,Zacho M,et al.Thrombelastographic haemostatic starus and antiplatelet therapy after coronary artery bypass surgery (TEG-CABG trial):assessing and monitoring the antithrombotic effect of clopidogrel and aspirin versus aspirin alone in hypercoagulable patients:study protocol for a randomized controlled trial.Trials,2012,13:48.
  • 10Shulga O,Bornstein N.Antiplatelets in secondary stroke prevention.Front Neurol,2011,2:36.

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部